Is Pembrolizumab a self-pay drug?

Pembrolizumab is a drug that works with the body's immune system to treat certain cancers. Pembrolizumab can cause your immune system to attack normal organs and tissues in any part of your body and affect the way they work. These problems sometimes become serious or life-threatening and can lead to death. These problems can occur at any time during treatment and even after treatment has ended.

Pembrolizumab is a highly selective IgG4-k humanized monoclonal antibody targeting the PD-1 receptor. It can also be called a checkpoint inhibitor and is used to treat a variety of cancers. Target and block a protein (receptor) called PD-1 on the surface of these T cells. It also blocks another protein called PD-L1. Pembrolizumab helps the immune system find and attack cancer cells by blocking PD-1 or PD-L1. Before a patient receives pembrolizumab, doctors may test cancer cells to check whether pembrolizumab may be an effective treatment

PembrolizumabThe original drug is already on the market in China. SpecificationsThe price per box of 100mg/4ml may be around 15,000 yuan. This drug is a strictly controlled drug and is not yet included in the medical insurance. Therefore, pembrolizumab purchased in China is a self-paid drug. Pembrolizumab The price of the European version of the original drug 100mg/4ml per box may be around RMB 25,000, and the price of the Turkish version of 100mg/4ml per box may be around 10,000 RMB (the price may fluctuate due to the exchange rate). The ingredients of the original drugs at home and abroad are basically the same, and they are expensive. There are currently no generic versions of Pembrolizumab available overseas.